查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941434

人工智慧藥物發現市場規模、佔有率和趨勢分析報告：按應用、治療領域、最終用途、地區和細分市場預測，2026-2033年

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

人工智慧藥物研發市場概述

2025年全球人工智慧藥物發現市場規模估計為23.5億美元，預計到2033年將達到137.7億美元。

預計從 2026 年到 2033 年，該市場將以 24.8% 的複合年成長率成長。對經濟高效的藥物開發的需求不斷成長、藥物再利用臨床試驗數量的增加以及慢性病患病率的上升是推動市場成長的關鍵因素。

此外，對精準醫療和標靶藥物研發的日益重視，以及運算能力和雲端基礎設施的提升，也正在推動市場成長。對具成本效益藥物研發策略日益成長的需求，是人工智慧在藥物發現產業發展的主要驅動力。根據2025年10月發表在《藥理學前沿》（Frontiers in Pharmacology）上的報導，傳統的藥物研發需要超過10年的漫長週期，每種藥物的成本通常超過20億美元。人工智慧在藥物發現和仿單標示外的應用，透過將已獲已通過核准或在臨床實驗藥物用於新的適應症，提供了一種避免早期安全性測試的策略。藥物再利用可望降低風險，並將上市時間從3年縮短至12年，平均投資額為3億美元。

人工智慧透過快速分析海量的生物學、化學和臨床數據，識別新的藥物-疾病關聯，加速這一進程。這縮短了研發時間和成本，為製藥公司和醫療機構提供了經濟可行的替代方案，無需從頭開始研發新藥。將人工智慧與藥物重定位結合，既能提高效率，又能降低相關風險和投資，有效解決了產業面臨的關鍵挑戰。人工智慧還能高效分析龐大的化合物庫、生物醫學文獻、體學資料集和真實世界證據，從而識別出數量有限但機率極高的候選藥物，無需進行大量的經驗篩檢，進一步增強了這一經濟優勢。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 人工智慧在藥物發現領域的市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 案例研究結果
  • 用於藥物發現的人工智慧市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章：人工智慧藥物發現市場：按應用領域分類的估算與趨勢分析

  • 全球人工智慧藥物發現市場：按應用領域分析變化
  • 2021-2033年全球人工智慧藥物發現市場規模及應用趨勢
  • 藥物的最佳化與再利用
  • 臨床前試驗
  • 其他

第5章：人工智慧藥物研發市場：按治療領域分類的估算與趨勢分析

  • 全球人工智慧藥物研發市場：按治療領域分析變化
  • 2021-2033年全球人工智慧藥物研發市場規模及依治療領域分類的趨勢
  • 腫瘤學
  • 神經退化性疾病
  • 心血管疾病
  • 代謝性疾病
  • 感染疾病
  • 其他

第6章：人工智慧藥物發現市場：按最終用途分類的估算和趨勢分析

  • 全球人工智慧藥物研發市場：按最終用途分類的差異分析
  • 2021-2033年全球人工智慧藥物研發市場規模及最終用途趨勢
  • 製藥和生物技術公司
  • CRO
  • 學術和研究機構
  • 其他

第7章：人工智慧藥物研發市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 2025年商業市場分析
  • 公司簡介/列表
    • Healx
    • BostonGene Corporation
    • BenevolentAI
    • Innophore
    • Delta4.ai
    • BioXcel Therapeutics Inc.
    • BullFrog AI Holdings, Inc.
    • Graphwise
    • Owkin, Inc
    • Insilico Medicine
    • IBM
    • Exscientia
    • Google（DeepMind）
    • BioSymetrics, Inc.
    • BPGbio Inc.（Berg Health）
    • Atomwise Inc.
    • Recursion
    • Aitia
    • Insitro
Product Code: GVR-4-68039-029-7

Artificial Intelligence In Drug Discovery Market Summary

The global artificial intelligence in drug discovery market size was estimated at USD 2.35 billion in 2025 and is projected to reach USD 13.77 billion by 2033, growing at a CAGR of 24.8% from 2026 to 2033. The rising demand for cost-effective drug development, the increasing number of clinical trials in drug repurposing, and the growing prevalence of chronic diseases are significant factors contributing to market growth.

In addition, the growing focus on precision medicine and targeted drug development, as well as improvements in computing power and cloud infrastructure, are other factors fueling market growth. The rising demand for cost-effective drug development strategies substantially drives the growth of artificial intelligence (AI) in the drug discovery industry. According to an article published in the Frontiers in Pharmacology Journal in October 2025, Traditional drug discovery involves lengthy timelines, often exceeding a decade, and costs frequently exceed USD 2 billion per drug. AI in drug discovery and repurposing offers a strategy to bypass early-stage safety testing by focusing on approved or investigational drugs for new indications. Drug repurposing is anticipated to reduce risks and bring drugs to the market in 3-12 years, with an average investment of USD 300 million.

AI accelerates this process by rapidly analyzing extensive biological, chemical, and clinical datasets to identify novel associations between drugs and diseases. This reduces development timelines and costs, offering pharmaceutical companies and healthcare providers an economically viable alternative to the development of new drugs. Integrating artificial intelligence with drug repurposing effectively addresses key industry challenges by enhancing productivity while reducing associated risks and investments. AI enhances this economic advantage by efficiently analyzing extensive chemical libraries, biomedical literature, omics datasets, and real-world evidence to identify a limited set of high-probability candidates, rather than supporting broad empirical screening.

Global Artificial Intelligence In Drug Discovery Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial intelligence in drug discovery market report based on application, therapeutic area, end use, and region.

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug optimization and repurposing
  • Preclinical testing
  • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Application Segment
    • 1.2.2. Therapeutic Area
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for cost-effective drug development
      • 3.2.1.2. Increasing clinical trials in drug repurposing
      • 3.2.1.3. Growing focus on precision medicine and targeted drug development
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Highly regulated industry
      • 3.2.2.2. High computational costs and infrastructure requirements
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Study Insights
  • 3.4. Artificial Intelligence in Drug Discovery Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Artificial Intelligence in Drug Discovery Market Application Movement Analysis
  • 4.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Drug optimization and repurposing
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Preclinical testing
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Artificial Intelligence in Drug Discovery Market Therapeutic Area Movement Analysis
  • 5.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Neurodegenerative Diseases
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Cardiovascular Disease
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Metabolic Diseases
    • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Infectious Disease
    • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence in Drug Discovery Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Artificial Intelligence in Drug Discovery Market End Use Movement Analysis
  • 6.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Contract Research Organizations (CROs)
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Academic and Research Institutes
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Other
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Healx
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. BostonGene Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. BenevolentAI
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Innophore
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Delta4.ai
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. BioXcel Therapeutics Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. BullFrog AI Holdings, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Graphwise
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Owkin, Inc
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Insilico Medicine
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. IBM
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Exscientia
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Google (DeepMind)
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. BioSymetrics, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. BPGbio Inc. (Berg Health)
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Atomwise Inc.
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Recursion
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. Aitia
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Product benchmarking
      • 8.4.18.4. Strategic initiatives
    • 8.4.19. Insitro
      • 8.4.19.1. Company overview
      • 8.4.19.2. Financial performance
      • 8.4.19.3. Product benchmarking
      • 8.4.19.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Artificial Intelligence In Drug Discovery Market, By Region, 2021 - 2033 (USD Million)
  • Table 3 Global Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 4 Global Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 5 Global Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 North America Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 7 North America Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 8 North America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 9 North America Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 US Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 US Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 12 US Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 Canada Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 15 Canada Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 17 Mexico Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 18 Mexico Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 21 Europe Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 22 Europe Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 UK Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 UK Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 25 UK Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 26 Germany Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 27 Germany Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 28 Germany Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 France Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 30 France Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 31 France Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 Italy Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 34 Italy Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 36 Spain Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 37 Spain Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 Denmark Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40 Denmark Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 42 Sweden Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 43 Sweden Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Norway Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 46 Norway Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 China Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 52 China Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 53 China Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Japan Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 55 Japan Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 56 Japan Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 57 India Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 58 India Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 59 India Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 South Korea Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 62 South Korea Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 63 Australia Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 64 Australia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65 Australia Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 67 Thailand Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 68 Thailand Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 71 Latin America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 72 Latin America Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 Brazil Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75 Brazil Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 77 Argentina Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 78 Argentina Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 81 MEA Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 82 MEA Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 84 South Africa Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 85 South Africa Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 UAE Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91 UAE Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 Artificial intelligence in drug discovery market: Market outlook
  • Fig. 6 Artificial intelligence in drug discovery market: Segment outlook
  • Fig. 7 Artificial intelligence in drug discovery market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 Artificial intelligence in drug discovery market driver impact
  • Fig. 10 Artificial intelligence in drug discovery market restraint impact
  • Fig. 11 Artificial intelligence in drug discovery market: Application outlook and key takeaways
  • Fig. 12 Artificial intelligence in drug discovery market: Application movement analysis
  • Fig. 13 Drug optimization and repurposing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Preclinical testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Computer vision market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Artificial intelligence in drug discovery market: Therapeutic Area outlook and key takeaways
  • Fig. 18 Artificial intelligence in drug discovery market: Therapeutic Area movement analysis
  • Fig. 19 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Neurodegenerative diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Cardiovascular disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Metabolic diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Infectious disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Artificial intelligence in drug discovery market: End use outlook and key takeaways
  • Fig. 26 Artificial intelligence in drug discovery market: End use movement analysis
  • Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Contract research organizations (CROs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Global Artificial intelligence in drug discovery market: Regional outlook and key takeaways
  • Fig. 32 Global Artificial intelligence in drug discovery market: Regional movement analysis
  • Fig. 33 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 US key country dynamics
  • Fig. 35 US market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico key country dynamics
  • Fig. 39 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Japan key country dynamics
  • Fig. 59 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 China key country dynamics
  • Fig. 61 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea key country dynamics
  • Fig. 67 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Australia key country dynamics
  • Fig. 69 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina key country dynamics
  • Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa key country dynamics
  • Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia key country dynamics
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 UAE key country dynamics
  • Fig. 81 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait key country dynamics
  • Fig. 83 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)